{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T02:11:08Z","timestamp":1772331068793,"version":"3.50.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6,1]]},"DOI":"10.1093\/humrep\/dem033","type":"journal-article","created":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T20:13:12Z","timestamp":1173384792000},"page":"1540-1546","source":"Crossref","is-referenced-by-count":35,"title":["Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development"],"prefix":"10.1093","volume":"22","author":[{"given":"Trifon G.","family":"Lainas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George K.","family":"Petsas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis Z.","family":"Zorzovilis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George S.","family":"Iliadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George T.","family":"Lainas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haris E.","family":"Cazlaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstratios M.","family":"Kolibianakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,3,8]]},"reference":[{"key":"key\n\t\t\t\t20171012105205_DEM033C1","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/humrep\/17.4.874","article-title":"GnRH antagonist in assisted reproduction: a Cochrane review","volume":"17","author":"Al-Inany","year":"2002","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012105205_DEM033C2","first-page":"567","article-title":"Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol","volume":"10","author":"Al-Inany","year":"2005","journal-title":"RBM Online"},{"key":"key\n\t\t\t\t20171012105205_DEM033C3","first-page":"84","article-title":"Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study","volume":"50","author":"Bahceci","year":"2005","journal-title":"J Reprod Med"},{"key":"key\n\t\t\t\t20171012105205_DEM033C4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0015-0282(97)00542-6","article-title":"Prospective evaluation of endometrial thickness as a predictor of pituitary down-regulation after gonadotropin-releasing hormone analogue administration in an in vitro fertilization program","volume":"69","author":"Barash","year":"1998","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012105205_DEM033C5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1471-0528.1995.tb10840.x","article-title":"Diagnosis, prevention and management of ovarian hyperstimulation syndrome","volume":"102","author":"Brinsden","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"key\n\t\t\t\t20171012105205_DEM033C6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/humupd\/dmh004","article-title":"A review of ten years experience of ICSI","volume":"10","author":"Devroey","year":"2004","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20171012105205_DEM033C7","first-page":"2790","article-title":"Hyperandrogenism, hirsutism, and the polycystic ovary syundrome","volume-title":"Endocrinology","author":"Ehrmann","year":"2006"},{"key":"key\n\t\t\t\t20171012105205_DEM033C8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0015-0282(02)04696-4","article-title":"Concurrent ganirelix and follitropin beta therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome","volume":"79","author":"Elkind-Hirsch","year":"2003","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012105205_DEM033C9","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.fertnstert.2005.02.011","article-title":"Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?","volume":"83","author":"Fauser","year":"2005","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012105205_DEM033C10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/humupd\/8.6.543","article-title":"The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction","volume":"8","author":"Filicori","year":"2002","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20171012105205_DEM033C11","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1093\/humrep\/dei086","article-title":"GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry","volume":"20","author":"Griesinger","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012105205_DEM033C12","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/humrep\/deh375","article-title":"Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study","volume":"19","author":"Hwang","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012105205_DEM033C13","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1210\/jc.2003-030805","article-title":"Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles","volume":"88","author":"Kolibianakis","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171012105205_DEM033C14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0015-0282(02)04920-8","article-title":"Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy","volume":"79","author":"Kolibianakis","year":"2003","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012105205_DEM033C15","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.0001-6349.2004.00480.x","article-title":"GnRH antagonists in poor responders","volume":"83","author":"Kolibianakis","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"key\n\t\t\t\t20171012105205_DEM033C16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1472-6483(10)61113-3","article-title":"GnRH antagonists in IVF","volume":"10","author":"Kolibianakis","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20171012105205_DEM033C17","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1093\/humrep\/dei106","article-title":"In a flexible antagonist protocol, earlier, criteria-based initiation of GnRH antagonist is associated with increased pregnancy rates in IVF","volume":"20","author":"Lainas","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012105205_DEM033C18","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1093\/humrep\/dei210","article-title":"Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment","volume":"20","author":"Messinis","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012105205_DEM033C19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","article-title":"Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment","volume":"58","author":"Navot","year":"1992","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012105205_DEM033C20","first-page":"131","article-title":"Classification, pathophysiology and management of ovarian hyperstimulation syndrome","volume-title":"In Vitro Fertilization and Assisted Reproduction","author":"Rizk","year":"1993"},{"key":"key\n\t\t\t\t20171012105205_DEM033C21","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1093\/humrep\/13.11.3023","article-title":"A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon)","volume":"13","author":"The ganirelix dose-finding study group","year":"1998","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20171012105205_DEM033C22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.fertnstert.2005.05.077","article-title":"Conventional in vitro fertilization versus intracytoplasmic sperm injection in patients with borderline semen: a randomized study using sibling oocytes","volume":"85","author":"van der Westerlaken","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012105205_DEM033C23","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.fertnstert.2004.10.054","article-title":"Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization procedure","volume":"83","author":"Van Landuyt","year":"2005","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012105205_DEM033C24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0301-2115(99)00080-9","article-title":"Intracytoplasmic sperm injection is not associated with poor outcome in couples with normal semen parameters and previous idiopathic fertilization failure in conventional in vitro fertilization","volume":"87","author":"Vicdan","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key\n\t\t\t\t20171012105205_DEM033C25","article-title":"Laboratory Manual for the Examination of Human Semen and Sperm-cervical Mucus Interaction","author":"WHO","year":"1999","edition":"4th edn"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/22\/6\/1540\/1669623\/dem033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T10:52:11Z","timestamp":1507805531000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/22\/6\/1540\/608504\/Initiation-of-GnRH-antagonist-on-Day-1-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,8]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2007,3,8]]},"published-print":{"date-parts":[[2007,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dem033","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2007,6]]},"published":{"date-parts":[[2007,3,8]]}}}